ACIU

AC Immune · USD

Market open US (NYSE / Nasdaq) · 09:30–16:00 · Mon 15:43 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About AC Immune

AC Immune is a biopharmaceutical company focused on developing therapies for neurodegenerative diseases such as Alzheimer's disease. They are primarily involved in the Healthcare sector.

HealthcareBiotechnologyPharmaceuticalsResearch
TickerACIU
NameAC Immune
CurrencyUSD
SectorHealthcare

Reputation

😎
How liked 50/100
From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

good bad neutral closed

Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BEARISH
1.32
RSI (14)i
2.53
SMA 20i
2.81
SMA 50i
2.97
SMA 200i
0.00%
1di
-2.44%
1wi
-21.61%
1mi
2.43%
30d voli
3.99
52w highi
1.83
52w lowi
-44.99%
from highi
-0.19
MACDi
Downtrend (50d below 200d)Oversold (RSI 1)MACD bearish crossover

Computed from 257 locally-stored price bars.

AI signals

  • HOLD 70% · long_term 2026-06-08 10:04

    The stock has been in a downtrend with significant losses over the past week, and there are no recent positive news to counterbalance this negative momentum. The current price is near its lowest point of the window, suggesting continued caution.

    qwen2.5:3b

Related news

  • No matched headlines yet.